In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 3080-99-7, name is 3,4-Dihydro-2H-benzo[b][1,4]thiazine, introducing its new discovery. Recommanded Product: 3,4-Dihydro-2H-benzo[b][1,4]thiazine
Nitrogen-containing fused ring compounds and use thereof
A URAT1 activity inhibitor containing a nitrogen-containing fused ring compound represented by the following formula [1]: [image] wherein each symbol is as defined in the description. The present invention is useful for the prophylaxis or treatment of pathology showing involvement of uric acid, such as hyperuricemia, gouty tophus, acute gouty arthritis, chronic gouty arthritis, gouty kidney, urolithiasis, renal function disorder, coronary artery disease, ischemic heart disease and the like.
We¡¯ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 3080-99-7, and how the biochemistry of the body works.Recommanded Product: 3,4-Dihydro-2H-benzo[b][1,4]thiazine
Reference£º
Thiazine – an overview | ScienceDirect Topics,
Thiazine | C4H5NS – PubChem